Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 9991-10000 of 13616

Page
per page
  1. PPDA
    B5312 PPDA
    Summary: Subtype-selective NMDA receptor antagonist
  2. SR 16584
    B5591 SR 16584
    Summary: α3β4 nAChR antagonist
      Soluble in DMSO
  3. GSK J2
    B5685 GSK J2
    Summary: inactive control of GSK J1, JMJD3 (KDM6B) and UTX (KDM6A) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.2 mg/mL
  4. Methoxy-X04
    B5769 Methoxy-X04
     3 Citation
    Summary: fluorescent amyloid β (Aβ) probe
      ≥51.9 mg/mL
  5. L-Quisqualic acid
    B6221 L-Quisqualic acid
    Summary: AMPA receptors and metabotropic glutamate receptors agonist
      Soluble in H2O or NaOH
  6. BMS 309403
    B7794 BMS 309403
     6 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL
  7. CVT 10216
    B4928 CVT 10216
    Summary: reversible inhibitor of aldehyde dehydrogenase 2 (ALDH2)
      ≥52.4 mg/mL
  8. BLU9931
    A8706 BLU9931
    Target: FGFR
    Summary: FGFR4 inhibitor,potent and irreversible
      ≥50.9 mg/mL
  9. FTI 277 HCl
    B5842 FTI 277 HCl
    Summary: FTase inhibitor
      ≥0.67 mg/mL
  10. RQ-00203078
    B5872 RQ-00203078
    Summary: Selective and orally active TRPM8 antagonist
      insoluble in H2O; ≥18.85 mg/mL

Items 9991-10000 of 13616

Page
per page